Austria · Series A startup

Who invested in ProtAffin Biotechnologie

3 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 26 Oct 2026

$7.1Mraised across 3 rounds since 2006, from 3 sources

$1.6MVenture$3.6MSeries A$2.0MSeries A
Latest round
Series A, $2.0MJan 2008
Biggest round
$3.6MSeries A · May 2007
Investors
4
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

200620072008
$1.6MVenture$3.6MSeries A$2.0MSeries A
First round
Venture, $1.6M
Jan 2006
Biggest round
$3.6M
Series A · May 2007
Usual gap between rounds
16 months
the median of 2

The rounds

  1. Jan 2008
    Series A$2.0M2 returning

    From a historical funding record

  2. May 2007
    Series A$3.6M2 new

    Reported by 2a.protaffin.com

  3. Jan 2006
    Venture$1.6M2 new

    From a historical funding record

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

AescapGovernment2rounds
Z-CubeVC firm2rounds
Haller CapitalGovernment1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about ProtAffin Biotechnologie

Who invested in ProtAffin Biotechnologie?

ProtAffin Biotechnologie's investors include Aescap, Z-Cube, Haller Capital and aws Austria Wirtschaftsservice Gesellschaft.

How much has ProtAffin Biotechnologie raised?

ProtAffin Biotechnologie has raised $7.1M across 3 rounds since 2006.

When did ProtAffin Biotechnologie last raise?

ProtAffin Biotechnologie's most recent round was a Series A of $2.0M in Jan 2008.

What was ProtAffin Biotechnologie's biggest round?

ProtAffin Biotechnologie's largest round on record is $3.6M (Series A), in May 2007.

Who backed ProtAffin Biotechnologie first?

ProtAffin Biotechnologie's first round on record, in Jan 2006, was backed by Haller Capital and aws Austria Wirtschaftsservice Gesellschaft.

What stage is ProtAffin Biotechnologie at?

ProtAffin Biotechnologie's latest named round is a Series A, in Jan 2008.

Where is ProtAffin Biotechnologie based?

ProtAffin Biotechnologie is based in Austria.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.